<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04122638</url>
  </required_header>
  <id_info>
    <org_study_id>GoztepeTRH</org_study_id>
    <nct_id>NCT04122638</nct_id>
  </id_info>
  <brief_title>Prevalence of Sarcopenia and Sarcopenic Obesity in Older Adults</brief_title>
  <official_title>Prevalence of Sarcopenia and Sarcopenic Obesity in Community-dwelling Outpatient Older Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Goztepe Training and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Istanbul Medeniyet University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Istanbul University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Goztepe Training and Research Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
  </oversight_info>
  <brief_summary>
    <textblock>
      Syndromes such as sarcopenia, sarcopenic obesity and osteosarcopenic obesity are commonly
      seen in older adults. They result from the impairment of muscle, bone and adipose tissue.
      Thus, they lead to a decrease in quality of life and increase morbidity and mortality. The
      aim of this study is to report the prevalence of sarcopenia, sarcopenic obesity and
      osteosarcopenic obesity in community-dwelling outpatient older adults and to investigate the
      related factors.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 7, 2019</start_date>
  <completion_date type="Actual">January 1, 2020</completion_date>
  <primary_completion_date type="Actual">January 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Handgrip Strength</measure>
    <time_frame>10 minutes</time_frame>
    <description>Handgrip strength measured by Takei© Hand Dynamometer</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Muscle mass</measure>
    <time_frame>5 minutes</time_frame>
    <description>Using Bioimpedance analysis (BİA) technique with TANITA© TBF 300</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Bone density</measure>
    <time_frame>30 minutes</time_frame>
    <description>T score evaluation using Dual-energy X-ray absorptiometry (DEXA)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of body fat</measure>
    <time_frame>5 minutes</time_frame>
    <description>Using Bioimpedance analysis (BİA) technique with TANITA© TBF 300</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Gait speed</measure>
    <time_frame>3 minutes</time_frame>
    <description>4-m usual walking speed test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical Activity</measure>
    <time_frame>5-10 minutes</time_frame>
    <description>Using Rapid Assessment of Physical Activity (RAPA)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nutritional Status</measure>
    <time_frame>10 minutes</time_frame>
    <description>Assessed with Mini-Nutritional Assessment (MNA)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Activities of Daily Living</measure>
    <time_frame>10 minutes</time_frame>
    <description>Activities of daily living assessed with Katz Index of Independence in Activities of Daily Living</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Instrumental Activities of Daily Living</measure>
    <time_frame>10 minutes</time_frame>
    <description>Instrumental activities of daily living assessed with Lawton -Brody Instrumental Activities of Daily Living Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Depression</measure>
    <time_frame>10 minutes</time_frame>
    <description>Assessed with The Geriatric Depression Scale- Short Form</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mini-Mental State Examination</measure>
    <time_frame>10-15 minutes</time_frame>
    <description>Mini-Mental State Examination</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood Sample Analysis</measure>
    <time_frame>5 minutes</time_frame>
    <description>A blood sample analysis including parameters such as: wbc, hgb, htc, mcv ,plt, fasting blood sugar, urea, uric acid, creatin, AST, ALP, ALT, GGT, LDH, total colesterol, trigylicerid, LDL, HDL, NA, K, Mg, Ca, P, Albumin, protrombin time, CRP, B12, folate, iron, ferritin, PTH, vitamin-D, sedimentation, TSH, T4, insukin, HGBA1C, IHOMA-IR.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comorbidities</measure>
    <time_frame>5 minutes</time_frame>
    <description>Assessed with Charlson Comorbidity Index</description>
  </secondary_outcome>
  <enrollment type="Actual">572</enrollment>
  <condition>Sarcopenia</condition>
  <condition>Sarcopenic Obesity</condition>
  <condition>Osteopenia, Osteoporosis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Community-dwelling older adults
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Being at the age of 65 or older

          -  Being able to complete 4-m walk test

        Exclusion Criteria:

          -  &lt;24 points on Mini-Mental State Examination

          -  12 points or higher on Geriatric Depression Scale
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Goztepe Training and Research Hospital</name>
      <address>
        <city>Istanbul</city>
        <zip>34722</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>October 7, 2019</study_first_submitted>
  <study_first_submitted_qc>October 9, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 10, 2019</study_first_posted>
  <last_update_submitted>February 26, 2020</last_update_submitted>
  <last_update_submitted_qc>February 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Goztepe Training and Research Hospital</investigator_affiliation>
    <investigator_full_name>Filiz Demirdağ</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Older adults</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoporosis</mesh_term>
    <mesh_term>Bone Diseases, Metabolic</mesh_term>
    <mesh_term>Sarcopenia</mesh_term>
    <mesh_term>Obesity</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

